Literature DB >> 26716167

Waiting times for prostate cancer diagnosis in KwaZulu-Natal, South Africa.

K Singh, E H Abdel Goad, S S Ramklass.   

Abstract

BACKGROUND: There is currently no evidence in the South African (SA) literature to suggest how long patients with clinically suspected prostate cancer (an elevated prostate-specific antigen level or abnormal findings on digital rectal examination) wait to have a prostate biopsy.
OBJECTIVES: To improve the overall efficiency of the prostate biopsy service offered at St Aidans Regional Hospital, Durban, SA, by quantifying the burden of disease and waiting times and to identify potential delays in management outcomes, thereby helping to alleviate patient anxiety during the stressful period of investigation.
METHODS: We did a retrospective folder review of patients who underwent trans-rectal prostate biopsy at St Aidan's Hospital, where the vast majority of prostate biopsies in the KwaZulu-Natal state healthcare sector are performed, from January to June 2013. The Statistical Package for Social Sciences was used for data analysis. Results. One hundred and six patients (mean age 67.6 years, 69.8% black Africans) underwent biopsy during the 6-month study period; 49.1% were found to have adenocarcinoma, and of the 80.1% of these who had a bone scan, 73.8% had skeletal metastases (p=0.1379). The median period of time from referral to biopsy was 55 days, from referral to first follow-up date (when the diagnosis is given and treatment options discussed or instituted) 100 days, and from biopsy to first follow-up date (i.e. waiting period to retrieve histological diagnosis) 36 days.
CONCLUSION: Despite the late presentation of prostate cancer in KZN, patients are waiting an average of 3 months from initial referral for a prostate biopsy to institution of definitive management.

Entities:  

Year:  2015        PMID: 26716167     DOI: 10.7196/samj.9192

Source DB:  PubMed          Journal:  S Afr Med J


  6 in total

1.  Waiting Times for Prostate Cancer Diagnosis in a Nigerian Population.

Authors:  Olufunmilade A Omisanjo; Olawale O Ogunremi; Olufemi O Akinola; Olaolu O Adebayo; Olufemi Ojewuyi; Mofeyisayo O Omorinde; Abimbola A Abolarinwa; Stephen O Ikuerowo; Fatai A Balogun
Journal:  J Cancer Epidemiol       Date:  2021-08-16

2.  Waiting times for prostate cancer: A review.

Authors:  Giacomo Lazzeri; Gianmarco Troiano; Barbara Rita Porchia; Federica Centauri; Vincenzo Mezzatesta; Giorgio Presicce; Daniela Matarrese; Roberto Gusinu
Journal:  J Public Health Res       Date:  2020-06-04

3.  Improving Timely Access to Diagnostic and Treatment Services for Lung Cancer Patients in KwaZulu-Natal, South Africa: Priority-Setting through Nominal Group Techniques.

Authors:  Buhle Lubuzo; Khumbulani W Hlongwana; Themba G Ginindza
Journal:  Int J Environ Res Public Health       Date:  2022-02-09       Impact factor: 3.390

4.  Prostate cancer survival in sub-Saharan Africa by age, stage at diagnosis, and human development index: a population-based registry study.

Authors:  Tobias P Seraphin; Walburga Y Joko-Fru; Shyam S Manraj; Eric Chokunonga; Nontuthuzelo I M Somdyala; Anne Korir; Guy N'Da; Anne Finesse; Henry Wabinga; Mathewos Assefa; Freddy Gnangnon; Rolf Hansen; Nathan G Buziba; Biying Liu; Eva J Kantelhardt; Donald M Parkin
Journal:  Cancer Causes Control       Date:  2021-07-10       Impact factor: 2.506

Review 5.  Role of Precision Oncology in Type II Endometrial and Prostate Cancers in the African Population: Global Cancer Genomics Disparities.

Authors:  Rahaba Marima; Rodney Hull; Mandisa Mbeje; Thulo Molefi; Kgomotso Mathabe; Abdulrahman M Elbagory; Demetra Demetriou; Zodwa Dlamini
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

6.  A modified Delphi study to identify screening items to assess neglected sexual side-effects following prostate cancer treatment.

Authors:  Pierre Röscher; Kimesh Naidoo; Joanne E Milios; Jacqueline M van Wyk
Journal:  BMC Urol       Date:  2022-03-11       Impact factor: 2.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.